Original Research Article
Regional Hypometabolism Related to Language Disturbance in Alzheimer’s DiseaseHirono N.a · Mori E.a · Ishii K.b · Ikejiri Y.a · Imamura T.a · Shimomura T.a · Ikeda M.a · Yamashita H.a · Takatsuki Y.a · Sasaki M.b
Departments of a Clinical Neurosciences and b Neuroimaging Research, Hyogo Institute for Aging Brain and Cognitive Disorders, Himeji, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
To elucidate the nature of language disturbance in Alzheimer’s disease (AD) and the cerebral area involved in it, we studied 65 AD patients with the Western Aphasia Battery (WAB) and with 18F-fluorodeoxyglucose and positron emission tomography. Partial correlations were evaluated between the Aphasia Quotient of WAB and regional cerebral glucose metabolism normalized by the mean metabolic rate in the bilateral primary sensorimotor areas after controlling age, sex, education and severity of illness. Language disturbance in AD is accounted for by deficits in the semantic processing of language and is related to glucose hypometabolism in the inferior temporal gyrus and inferior parietal lobule, especially in the dominant side. These results offer further evidence suggesting that the lexico-semantic processing system is mediated in these regions.
Alzheimer A: Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psych Gerichtl Med 1907;64:146–158; translated by Jarvik L, Greenson H in Alzheimer Dis Assoc Disord 1987;1:7–8.
- Appel J, Kertesz A, Fisman M: A study of language functioning in Alzheimer patients. Brain Lang 1982;17:73–91.
- Cummings JL, Benson F, Hill MA, Read S: Aphasia in dementia of the Alzheimer type. Neurology 1985;35:394–397.
- Seltzer B, Sherwin I: A comparison of clinical features in early- and late-onset primary degenerative dementia. Arch Neurol 1983;40:143–146.
- Folstein MF, Breitner JCS: Language disorder predicts familial Alzheimer disease. Johns Hopkins Med J 1981;149:145–147.
- Huff FJ, Corkin S, Growdon JH: Semantic impairment and anomia in Alzheimer’s disease. Brain Lang 1986;28:235–249.
Cummings JL, Benson DF: Dementia: A Clinical Approach, ed 2. Boston, Butterworth-Heinemann, 1992.
- Grady CL, Haxby JV, Schlageter NL, Berg G, Rapoport SI: Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 1986;36:1390–1392.
- Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, Rapoport SI: Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 1988;38:1853–1863.
- Hunter R, McLuskie R, Wyper D, Patterson J, Christie JE, Brooks DN, McCulloch J, Fink G, Goodwin GM: The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer’s disease and Korsakoff’s psychosis. Psychol Med 1989;19:847–855.
- Nybäck H, Nyman H, Blomqvist G, Sjögren I, Stone-Elander S: Brain metabolism in Alzheimer’s dementia: Studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672–678.
- O’Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R: A study of regional cerebral blood flow and cognitive performance in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1992;55:1182–1187.
Kertesz A: The Western Aphasia Battery. New York, Grune & Stratton, 1982.
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
- Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
Kertesz A: Aphasia and associated disorders: Taxonomy, localization, and recovery. New York, Grune & Stratton, 1979.
- Horner J, Dawson DV, Heyman A, Fish AM: The usefulness of the Western Aphasia Battery for differential diagnosis of Alzheimer dementia and focal stroke syndromes: Preliminary evidence. Brain Lang 1992;42:77–88.
Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K, Hirose Y, Amano M, Yamamoto S, Tanaka K: Design of evaluation of Headtome IV: A whole body positron emission tomograph. IEEE Trans Nucl Sci 1989;NS-37:1006–1010.
Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Thieme, 1988.
- Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M: The [14C]deoxy glucose method for the measurement of local cerebral glucose utilization, theory, procedure, and normal values in the conscious and anaesthetized albino rat. J Neurochem 1977;28:897–916.
- Reivich M, Alavi A, Wolf A, Fowler J, Russel J, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH: Glucose metabolic rate for kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab 1985;5:179–192.
- Ishii K, Kitagaki H, Kono M, Mori E: Decreased medial temporal oxygen metabolism in Alzheimer’s disease shown by positron emission tomography. J Nucl Med 1996;37:1159–1165.
- Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). V. A normative study of the neuropsychological battery. Neurology 1994;44:609–614.
- Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC: Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: A CERAD analysis. XII. Neurology 1996;46:136–141.
SAS Institute Inc: SAS/STAT User’s Guide, Release 6.03 Edition. Cary, SAS Institute, 1988.
- Martin A, Fedio P: Word production and comprehension in Alzheimer’s disease. The breakdown of semantic knowledge. Brain Lang 1983;19:124–141.
- Chertkow H, Bub D: Semantic memory loss in dementia of Alzheimer’s type. What do various measures measure? Brain 1990;113:397–417.
- Hodges JR, Salmon DP, Butters N: Semantic memory impairment in Alzheimer’s disease: Failure of access or degraded knowledge? Neuropsychologia 1992;30:301–314.
Chan AS, Butters N, Paulsen JS, Salmon DP, Swenson MR, Maloney LT: An assessment of the semantic network in patients with Alzheimer’s disease. J Cogn Neurosci 1993;5:254–261.
- Binetti G, Magni E, Cappa SF, Padovani A, Bianchetti A, Trabucchi M: Semantic memory in Alzheimer’s disease: An analysis of category fluency. J Clin Exp Neuropsychol 1995;17:82–89.
- Hodges JR, Patterson K: Is semantic memory consistently impaired early in the course of Alzheimer’s disease? Neuroanatomical and diagnostic implications. Neuropsychologia 1995;33:441–459.
- Smith S, Faust M, Beeman M, Kennedy L, Perry D: A property level analysis of lexical semantic representation in Alzheimer’s disease. Brain Lang 1995;49:263–279.
- Silveri MC, Daniele A, Giustolisi L, Gainotti G: Dissociation between knowledge of living and nonliving things in dementia of the Alzheimer type. Neurology 1991;41:545–546.
- Mauri A, Daum I, Sartori G, Riesch G, Birbaumer N: Category-specific semantic impairment in Alzheimer’s disease and temporal lobe dysfunction: A comparative study. J Clin Exp Neuropsychol 1994;16:689–701.
- Schwartz MF, Marin OS, Saffran EM: Dissociations of language function in dementia: A case study. Brain Lang 1979;7:277–306.
- Warrington EK, Shallice T: Category specific semantic impairments. Brain 1984;107:829–854.
- Farah MJ, Hammond KM, Mehta Z, Ratcliff G: Category-specificity and modality-specificity in semantic memory. Neuropsychologia 1989;27:193–200.
- Hodges JR, Patterson K, Oxbury S, Funnell E: Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783–1806.
- Pietrini V, Nertempi P, Vaglia A, Revello MG, Pinna V, Ferro-Milone F: Recovery from herpes simplex encephalitis: Selective impairment of specific semantic categories with neuroradiological correlation. J Neurol Neurosurg Psychiatry 1988;51:1284–1293.
- Sartori G, Job R, Miozzo M, Zago S, Marchiori G: Category-specific form-knowledge deficit in a patient with herpes simplex virus encephalitis. J Clin Exp Neuropsychol 1993;15:280–299.
- Warrington EK: The selective impairment of semantic memory. Q J Exp Psychol 1975;27:635–657.
- Démonet JF, Chollet F, Ramsay S, Cardebat D, Nespoulous JL, Wise R, Rascol A, Frackowiak R: The anatomy of phonological and semantic processing in normal subjects. Brain 1992;115:1753–1768.
- Creutzfeld O, Ojemann G, Lettich E: Neuronal activity in the human lateral temporal lobe. I. Responses to speech. Exp Brain Res 1989;77:451–475.
- Gainotti G, Silveri MC, Villa G, Miceli G: Anomia with and without lexical comprehension disorders. Brain Lang 1986;29:18–33.
- Hart J Jr, Gordon B: Delineation of single-word semantic comprehension deficits in aphasia, with anatomical correlation. Ann Neurol 1990;27:226–231.
- Zaidel E: Auditory vocabulary of the right hemisphere following brain bisection or hemidecortication. Cortex 1976;12:191–211.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.